Cargando…

Cefotaxime removal enhancement via bio-nanophotocatalyst α-Fe(2)O(3) using photocatalytic degradation technique and its echo-biomedical applications

The present paper evaluates the photocatalytic degradation (PCD) performance of the biofabricated hematite nanoparticles (α-HNPs) for the degradation approach of the Cefotaxime (Cfm). The optimum pH of the solution to achieve the best PCD was found to be 10.5. The kinetics study for the PCD of the C...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Hakkani, Mostafa F., Gouda, Gamal A., Hassan, Sedky H. A., Saddik, Mohammed S., El-Mokhtar, Mohamed A., Ibrahim, Maggie A., Mohamed, Mahmoud M. A., Nagiub, Adham M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279508/
https://www.ncbi.nlm.nih.gov/pubmed/35831423
http://dx.doi.org/10.1038/s41598-022-14922-3
_version_ 1784746415771090944
author Al-Hakkani, Mostafa F.
Gouda, Gamal A.
Hassan, Sedky H. A.
Saddik, Mohammed S.
El-Mokhtar, Mohamed A.
Ibrahim, Maggie A.
Mohamed, Mahmoud M. A.
Nagiub, Adham M.
author_facet Al-Hakkani, Mostafa F.
Gouda, Gamal A.
Hassan, Sedky H. A.
Saddik, Mohammed S.
El-Mokhtar, Mohamed A.
Ibrahim, Maggie A.
Mohamed, Mahmoud M. A.
Nagiub, Adham M.
author_sort Al-Hakkani, Mostafa F.
collection PubMed
description The present paper evaluates the photocatalytic degradation (PCD) performance of the biofabricated hematite nanoparticles (α-HNPs) for the degradation approach of the Cefotaxime (Cfm). The optimum pH of the solution to achieve the best PCD was found to be 10.5. The kinetics study for the PCD of the Cfm via α-HNPs has been investigated and the reaction was found to be fellow pseudo-first-order at R(2) = 0.992. The mass loading impact of α-HNPs was investigated and estimated for the maximum degradation of Cfm 0.4 mg/mL. UV–Vis confirmed that α-HNPs had a direct transition bandgap at 3.78 eV at a maximum absorption wavelength of 362 nm with suspension stability for 7 days. The probable mechanism of the Cfm PCD via α-HNPs and the degradation pathway was conducted. The validation of the suspension stability of the α-HNPs (−68.6 ± 11.8 mV) was determined using the zeta potential investigation test. XRD investigation was conducted after Cfm PCD showing an average crystallite size of 27.0 nm. XRD, TEM, SEM, EDX, and FT-IR analyses have been conducted for the α-HNPs before and after Cfm PCD confirming the high efficiency for the reusability of the current biocatalyst α-HNPs for further use. TEM results of the particle sizes of α-HNPs were found at 19.2 ± 4.4 and 20.6 ± 7.4 nm respectively before and after Cfm PCD. The efficiency of the Cfm PCD was found to be 99.1% after 6 h. High potent as an antibacterial agent of α-HNPs was investigated either α-HNPs alone or after its PCD activity against Cfm. The antibacterial activity revealed high sensitivity, especially toward Gram-positive species indicating its promising ability against pathogenic issues. Interestingly, Cfm@α-HNPs showed superior anti-proliferative activity as tested by MTT assay and were able to induce apoptosis in MCF7 and HepG2 cell lines using the flow cytometry technique at 20.7% and 17% respectively. Also, The IC(50) of hydrogen peroxide scavenging was estimated and it was manifested that 635.8 and 665.6 μg/mL of α-HNPs before and after the PCD process of Cfm respectively.
format Online
Article
Text
id pubmed-9279508
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-92795082022-07-15 Cefotaxime removal enhancement via bio-nanophotocatalyst α-Fe(2)O(3) using photocatalytic degradation technique and its echo-biomedical applications Al-Hakkani, Mostafa F. Gouda, Gamal A. Hassan, Sedky H. A. Saddik, Mohammed S. El-Mokhtar, Mohamed A. Ibrahim, Maggie A. Mohamed, Mahmoud M. A. Nagiub, Adham M. Sci Rep Article The present paper evaluates the photocatalytic degradation (PCD) performance of the biofabricated hematite nanoparticles (α-HNPs) for the degradation approach of the Cefotaxime (Cfm). The optimum pH of the solution to achieve the best PCD was found to be 10.5. The kinetics study for the PCD of the Cfm via α-HNPs has been investigated and the reaction was found to be fellow pseudo-first-order at R(2) = 0.992. The mass loading impact of α-HNPs was investigated and estimated for the maximum degradation of Cfm 0.4 mg/mL. UV–Vis confirmed that α-HNPs had a direct transition bandgap at 3.78 eV at a maximum absorption wavelength of 362 nm with suspension stability for 7 days. The probable mechanism of the Cfm PCD via α-HNPs and the degradation pathway was conducted. The validation of the suspension stability of the α-HNPs (−68.6 ± 11.8 mV) was determined using the zeta potential investigation test. XRD investigation was conducted after Cfm PCD showing an average crystallite size of 27.0 nm. XRD, TEM, SEM, EDX, and FT-IR analyses have been conducted for the α-HNPs before and after Cfm PCD confirming the high efficiency for the reusability of the current biocatalyst α-HNPs for further use. TEM results of the particle sizes of α-HNPs were found at 19.2 ± 4.4 and 20.6 ± 7.4 nm respectively before and after Cfm PCD. The efficiency of the Cfm PCD was found to be 99.1% after 6 h. High potent as an antibacterial agent of α-HNPs was investigated either α-HNPs alone or after its PCD activity against Cfm. The antibacterial activity revealed high sensitivity, especially toward Gram-positive species indicating its promising ability against pathogenic issues. Interestingly, Cfm@α-HNPs showed superior anti-proliferative activity as tested by MTT assay and were able to induce apoptosis in MCF7 and HepG2 cell lines using the flow cytometry technique at 20.7% and 17% respectively. Also, The IC(50) of hydrogen peroxide scavenging was estimated and it was manifested that 635.8 and 665.6 μg/mL of α-HNPs before and after the PCD process of Cfm respectively. Nature Publishing Group UK 2022-07-13 /pmc/articles/PMC9279508/ /pubmed/35831423 http://dx.doi.org/10.1038/s41598-022-14922-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Al-Hakkani, Mostafa F.
Gouda, Gamal A.
Hassan, Sedky H. A.
Saddik, Mohammed S.
El-Mokhtar, Mohamed A.
Ibrahim, Maggie A.
Mohamed, Mahmoud M. A.
Nagiub, Adham M.
Cefotaxime removal enhancement via bio-nanophotocatalyst α-Fe(2)O(3) using photocatalytic degradation technique and its echo-biomedical applications
title Cefotaxime removal enhancement via bio-nanophotocatalyst α-Fe(2)O(3) using photocatalytic degradation technique and its echo-biomedical applications
title_full Cefotaxime removal enhancement via bio-nanophotocatalyst α-Fe(2)O(3) using photocatalytic degradation technique and its echo-biomedical applications
title_fullStr Cefotaxime removal enhancement via bio-nanophotocatalyst α-Fe(2)O(3) using photocatalytic degradation technique and its echo-biomedical applications
title_full_unstemmed Cefotaxime removal enhancement via bio-nanophotocatalyst α-Fe(2)O(3) using photocatalytic degradation technique and its echo-biomedical applications
title_short Cefotaxime removal enhancement via bio-nanophotocatalyst α-Fe(2)O(3) using photocatalytic degradation technique and its echo-biomedical applications
title_sort cefotaxime removal enhancement via bio-nanophotocatalyst α-fe(2)o(3) using photocatalytic degradation technique and its echo-biomedical applications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279508/
https://www.ncbi.nlm.nih.gov/pubmed/35831423
http://dx.doi.org/10.1038/s41598-022-14922-3
work_keys_str_mv AT alhakkanimostafaf cefotaximeremovalenhancementviabionanophotocatalystafe2o3usingphotocatalyticdegradationtechniqueanditsechobiomedicalapplications
AT goudagamala cefotaximeremovalenhancementviabionanophotocatalystafe2o3usingphotocatalyticdegradationtechniqueanditsechobiomedicalapplications
AT hassansedkyha cefotaximeremovalenhancementviabionanophotocatalystafe2o3usingphotocatalyticdegradationtechniqueanditsechobiomedicalapplications
AT saddikmohammeds cefotaximeremovalenhancementviabionanophotocatalystafe2o3usingphotocatalyticdegradationtechniqueanditsechobiomedicalapplications
AT elmokhtarmohameda cefotaximeremovalenhancementviabionanophotocatalystafe2o3usingphotocatalyticdegradationtechniqueanditsechobiomedicalapplications
AT ibrahimmaggiea cefotaximeremovalenhancementviabionanophotocatalystafe2o3usingphotocatalyticdegradationtechniqueanditsechobiomedicalapplications
AT mohamedmahmoudma cefotaximeremovalenhancementviabionanophotocatalystafe2o3usingphotocatalyticdegradationtechniqueanditsechobiomedicalapplications
AT nagiubadhamm cefotaximeremovalenhancementviabionanophotocatalystafe2o3usingphotocatalyticdegradationtechniqueanditsechobiomedicalapplications